Yasko Alan W
Department of Orthopaedic Surgery, Northwestern University, Feinberg School of Medicine, Orthopaedic Oncology, Chicago, IL USA.
Cancer Treat Res. 2009;152:125-45. doi: 10.1007/978-1-4419-0284-9_6.
Surgical strategies for the primary tumor for patients with extremity and pelvis osteosarcoma have evolved from the ablative to limb-sparing approaches over the past three decades. Favorable oncologic and functional outcomes with contemporary tissue-conserving techniques consistently observed in skeletally mature patients have prompted the application of similar approaches to a growing number of eligible skeletally immature patients. In response to emerging long-term outcome data, current strategies have focused principally on refining the nature and scope of surgical resection to preserve uninvolved tissues, and on the adoption of novel biological and nonbiological skeletal and soft-tissue reconstruction methods to optimize function. We focus on these clinical issues and discuss current efforts to advance the surgical management of the primary tumor and address the limitations of the definitive treatment of the primary tumor, including locally recurrent disease and complications of skeletal reconstructions.
在过去三十年中,肢体和骨盆骨肉瘤患者原发性肿瘤的手术策略已从根治性手术演变为保肢手术。在骨骼成熟患者中持续观察到当代组织保留技术具有良好的肿瘤学和功能结果,这促使越来越多符合条件的骨骼未成熟患者也采用类似方法。针对新出现的长期结果数据,当前策略主要集中在优化手术切除的性质和范围以保留未受累组织,以及采用新型生物和非生物骨骼及软组织重建方法以优化功能。我们关注这些临床问题,并讨论当前为推进原发性肿瘤的手术管理所做的努力,以及解决原发性肿瘤确定性治疗的局限性,包括局部复发性疾病和骨骼重建并发症。